A4i is a digital therapeutic and digital biomarker platform for severe mental illnesses. The platform features a mobile application used by patients and a clinical web portal to support care coordination by providers. A4i addresses critical gaps during pivotal points in the recovery process by providing tools that address auditory hallucinations, data collection for clinical decision support and data-driven readmission/relapse risk-detection. A4i has active deployments for schizophrenia and solutions are being developed for addiction, severe mood disorders, developmental disability populations.

Mission Objectives

A4i aims to meet, connect and build relationships with potential partners, investors and clients. These connections can lead to business opportunities to help us continue to build and provide the best platform for severe mental illnesses.

A4i Inc. logo



Event details

Date: June 26 - 29, 2023

Event contact

Lisa Qi
Senior International Market Consultant


172 in total